Androgen prohormone: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 28: | Line 28: | ||
{{Endocrinology-stub}} | {{Endocrinology-stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 18:24, 18 March 2025
Androgen prohormones are a class of hormones that serve as precursors to androgens, the primary male sex hormones. They are produced in the adrenal glands, ovaries, and testes, and play a crucial role in the development of male secondary sexual characteristics and the regulation of the menstrual cycle and pregnancy.
Production and Function[edit]
The production of androgen prohormones begins in the hypothalamus, which releases gonadotropin-releasing hormone (GnRH). This hormone stimulates the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH then stimulates the production of androgen prohormones in the gonads.
Androgen prohormones are converted into active androgens, such as testosterone and dihydrotestosterone, by the action of enzymes. These androgens then bind to androgen receptors in target tissues, triggering a range of physiological responses.
Clinical Significance[edit]
Abnormal levels of androgen prohormones can lead to a variety of health conditions. For example, elevated levels can result in hirsutism and polycystic ovary syndrome in women, while low levels can lead to hypogonadism in men.
Androgen prohormones are also used in hormone therapy for transgender men, to help them develop male secondary sexual characteristics. However, their use is controversial due to potential side effects, including an increased risk of cardiovascular disease and prostate cancer.
See Also[edit]
References[edit]
<references />

This article is a endocrinology stub. You can help WikiMD by expanding it!